Total Payments
$1,028
2024 Payments
$577.54
Companies
6
Transactions
37
Medicare Patients
632
Medicare Billing
$254,724
Payment Breakdown by Category
Food & Beverage$998.11 (97.1%)
Education$29.70 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $998.11 | 35 | 97.1% |
| Education | $29.70 | 2 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $441.97 | 16 | $0 (2024) |
| Alkermes, Inc. | $199.28 | 6 | $0 (2024) |
| Indivior Inc. | $139.53 | 5 | $0 (2024) |
| ABBVIE INC. | $122.86 | 5 | $0 (2024) |
| Braeburn Inc. | $105.71 | 4 | $0 (2024) |
| Orexo US, Inc. | $18.46 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $577.54 | 24 | Gilead Sciences, Inc. ($291.87) |
| 2023 | $227.87 | 6 | Gilead Sciences, Inc. ($150.10) |
| 2022 | $200.07 | 6 | Alkermes, Inc. ($155.00) |
| 2021 | $22.33 | 1 | AbbVie Inc. ($22.33) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $31.01 | General |
| Category: OUD | ||||||
| 12/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.72 | General |
| 11/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.08 | General |
| 11/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.93 | General |
| 11/20/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: VIROLOGY | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.37 | General |
| 10/31/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: VIROLOGY | ||||||
| 10/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.74 | General |
| 09/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.22 | General |
| 09/05/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: VIROLOGY | ||||||
| 08/28/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: Opioid Use Disorder | ||||||
| 08/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.79 | General |
| 07/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.95 | General |
| 07/24/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: CNS | ||||||
| 07/24/2024 | Alkermes, Inc. | VIVITROL (Drug) | Education | In-kind items and services | $14.85 | General |
| Category: CNS | ||||||
| 07/09/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: Opioid Use Disorder | ||||||
| 05/15/2024 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $18.46 | General |
| Category: Addiction Medicine | ||||||
| 05/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.27 | General |
| 05/01/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: OUD | ||||||
| 04/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.19 | General |
| 03/14/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: Opioid Use Disorder | ||||||
| 02/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.30 | General |
| 02/07/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $124.91 | General |
| Category: HCV | ||||||
| 02/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.40 | General |
| 12/20/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.01 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 135 | 712 | $83,370 | $52,755 |
| 2022 | 4 | 176 | 1,007 | $120,945 | $76,823 |
| 2021 | 4 | 142 | 748 | $110,800 | $61,385 |
| 2020 | 4 | 179 | 827 | $136,290 | $63,761 |
Total Patients
632
Total Services
3,294
Medicare Billing
$254,724
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 36 | 182 | $26,026 | $20,073 | 77.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 43 | 268 | $20,904 | $16,078 | 76.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 162 | $19,440 | $8,758 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 100 | $17,000 | $7,846 | 46.2% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 46 | 283 | $40,469 | $31,491 | 77.8% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 55 | 362 | $28,236 | $21,895 | 77.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 176 | $29,920 | $13,649 | 45.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 186 | $22,320 | $9,789 | 43.9% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 40 | 200 | $34,480 | $22,886 | 66.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 42 | 284 | $39,290 | $17,648 | 44.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 172 | $26,640 | $15,208 | 57.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 92 | $10,390 | $5,643 | 54.3% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 46 | 178 | $32,930 | $20,240 | 61.5% |
| 80307 | Testing for presence of drug | Office | 2020 | 56 | 328 | $52,480 | $20,201 | 38.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 64 | 279 | $41,850 | $16,762 | 40.1% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 13 | 42 | $9,030 | $6,558 | 72.6% |
About Robin Boone, NP
Robin Boone, NP is a Registered Nurse healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2016. The National Provider Identifier (NPI) number assigned to this provider is 1013364447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robin Boone, NP has received a total of $1,028 in payments from pharmaceutical and medical device companies, with $577.54 received in 2024. These payments were reported across 37 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($998.11).
As a Medicare-enrolled provider, Boone has provided services to 632 Medicare beneficiaries, totaling 3,294 services with total Medicare billing of $254,724. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Nurse Practitioner
- Location Greensboro, NC
- Active Since 05/16/2016
- Last Updated 07/11/2016
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1013364447
Products in Payments
- Epclusa (Drug) $249.82
- VIVITROL (Drug) $174.86
- SUBLOCADE (Drug) $139.53
- MAVYRET (Drug) $122.86
- BRIXADI (Drug) $105.71
- ARISTADA (Drug) $24.42
- Zubsolv (Drug) $18.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Greensboro
Mary Prevost, Np, NP
Registered Nurse — Payments: $10,173
Registered Nurse $10,173
Dr. Allan Faircloth, Dnp, Pmhnp-Bc, Rn, DNP, PMHNP-BC, RN
Registered Nurse — Payments: $5,546
Registered Nurse $5,546
Joyce Brunson, Dnp, Agacnp, Pmhnp, DNP, AGACNP, PMHNP
Registered Nurse — Payments: $3,917
Registered Nurse $3,917
Katie Hyatt, Ag-Np, AG-NP
Registered Nurse — Payments: $3,713
Registered Nurse $3,713
Brittany Turbeville, Np, NP
Registered Nurse — Payments: $2,953
Registered Nurse $2,953
Eunice Thomas
Registered Nurse — Payments: $2,884
Registered Nurse $2,884